In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
EVENTS
Kedrion Biopharma celebrates Primary Immunodeficiency Week
The company stands alongside PI patients associations around the globe
read moreEVENTS
Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
read moreEVENTS
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai
read more-
EVENTS - 17-04-2016
Kedrion initiatives for World Hemophilia Day 2016
The goal is to improve access to treatments for people suffering from hemorrhagic conditions
read more -
CORPORATE - 07-03-2016
CURhE, Global Alliance for mother and child healthcare
Kedrion among the founding members. The aim is Rh disease eradication
read more -
CORPORATE - 19-01-2016
Kedrion Biopharma strengthens its position on the US market
Granted exclusive rights to commercialize a lifesaving drug in the US
read more -
CORPORATE - 18-01-2016
A brand new location for KEDPlasma donors in the very center of Fürth
Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 